Work

Supplementary Figures 1 through 4 from Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Fig. S1. MRI of 4NQO-induced tumor growth. Supplementary Fig. S2. MRI-based assessment of response to 1,25(OH)2D3 alone and in combination with erlotinib in the 4NQO model. Supplementary Fig. S3. Ex vivo assessment of response to combination treatment in the 4NQO model. Supplementary Fig. S4. Histopathologic assessment of response to combination treatment in the 4NQO model.

DOI: 10.1158/1940-6207.22527113

Authors: Katelyn D. Bothwell, Tatiana Shaurova, Mihai Merzianu, Amritha Suresh, Moni A. Kuriakose, Candace S. Johnson, Pamela A. Hershberger, Mukund Seshadri

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362530356

Cites:

Cited by:

Related to: 10